A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The main objectives of the SRD part of this trial are to investigate safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of BI 1356225 in healthy male subjects following oral administration of single rising doses. The main objective of the BA part of this trial will be to explore the influence of food on the bioavailability of tablet fasted versus tablet fed
Epistemonikos ID: b85a101bcad6e4213e3ab779925ce8124feae3f7
First added on: May 22, 2024